PLVAP and atherosclerosis: According to the expression pattern during atherosclerosis progression in male Ldlr−/−Apob100/100 mice and the levels in male carotid plaques, the top key driver, PLVAP, constitutes a plausible target to modify the activity of GRN195 in males (Fig. 7h, upper panels).